-
How Sodium Overload Executes NECSO
2026-08-11
The Nature Communications study identifies mitochondrial energy failure as the mechanistic link between TRPM4-mediated sodium influx and necrosis by sodium overload, or NECSO. Its findings connect mitochondrial Na⁺ accumulation, NCLX-dependent Ca²⁺ loss, impaired oxidative metabolism, ATP depletion, and membrane rupture into a coherent causal pathway.
-
Probenecid as a Translational Mechanism Probe
2026-08-11
Probenecid is more than a broad transporter inhibitor: it is a useful mechanistic probe for connecting drug efflux, pannexin-1 biology, lysosomal injury, and neuroinflammatory responses. This thought-leadership guide shows how to use Probenecid to design stronger multidrug-resistance and cerebral ischemia/reperfusion studies while maintaining the specificity and translational discipline required for preclinical decision-making.
-
KPT-330 Inhibits Osteoclastogenesis in Osteoarthritis
2026-08-10
A 2026 iScience study identifies KPT-330, also known as Selinexor, as an inhibitor of osteoclast-driven subchondral bone remodeling in osteoarthritis. Using a DMM mouse model and RANKL-induced osteoclastogenesis assays, the authors link protection of bone and cartilage to suppression of NF-κB and MAPK signaling.
-
HA mRNA Vaccine Protects Dairy Cows Against H5N1
2026-08-09
A hemagglutinin-based mRNA–lipid nanoparticle vaccine protected lactating dairy cows against high-dose H5N1 challenge while preserving health and milk production. The study is notable for demonstrating durable protection even when serum antibody concentrations had declined substantially, although its reported findings do not establish which modified-nucleotide chemistry was used in the vaccine transcripts.
-
Pazopanib Hydrochloride Assay Workflows
2026-08-08
Build more informative kinase-inhibitor experiments with Pazopanib Hydrochloride by separating growth arrest from cell killing and aligning endpoints with the biological question. This workflow combines pathway-aware dosing, time-resolved viability measurements, and practical troubleshooting for angiogenesis, renal cell carcinoma, and soft tissue sarcoma studies.
-
SIRT3-SUMO, N-Glycosylation, and Asthma
2026-08-07
The reference study identifies a SIRT3-SUMO–FAO–N-glycosylation pathway that promotes regulatory T-cell differentiation and restrains asthma-associated inflammation. Its combination of network analysis, T-cell differentiation models, molecular perturbation, and in vivo asthma experiments provides a mechanistic framework for linking T-cell metabolism with disease heterogeneity.
-
Necrostatin-1 (Nec-1): Reliable RIP1 Kinase Inhibitor for As
2026-08-07
This authoritative article addresses laboratory challenges in cell death pathway research, focusing on the reproducibility and mechanistic clarity provided by Necrostatin-1 (Nec-1), (R)-5-([7-chloro-1H-indol-3-yl]methyl)-3-methylimidazolidine-2,4-dione (SKU A4213). By analyzing real-world assay scenarios, it demonstrates how this selective RIP1 kinase inhibitor from APExBIO enhances necroptosis studies through validated protocols and robust performance.
-
3-Bromopyruvate Induces Ferroptosis to Overcome Cetuximab Re
2026-08-06
This study demonstrates that 3-bromopyruvate, in combination with cetuximab, can overcome intrinsic and acquired resistance in colorectal cancer cells by promoting autophagy-dependent ferroptosis. The findings provide mechanistic insight into FOXO3a-mediated pathways and highlight promising therapeutic strategies for drug-resistant colorectal cancer.
-
Chenodeoxycholic Acid: FXR Agonist for Renal and Metabolic R
2026-08-06
Chenodeoxycholic Acid (CDCA) is a primary bile acid and potent FXR agonist used in cholesterol metabolism and kidney injury research. CDCA directly activates FXR to upregulate KLF11, suppressing JAK2/STAT3 signaling and protecting renal function. Its properties and evidence base make it a critical tool in metabolic and nuclear receptor signaling studies.
-
Sumatriptan: Systematic Review of Anti-Inflammatory Properti
2026-08-05
This systematic review establishes sumatriptan as more than a migraine therapy, highlighting robust anti-inflammatory effects via 5-HT1B/1D receptor pathways. The findings broaden its mechanistic relevance for inflammation models, with translational potential for cardiovascular and neuroimmune research.
-
Applied Workflows with the Dual Luciferase Reporter Gene Sys
2026-08-05
The Dual Luciferase Reporter Gene System delivers high-precision, simultaneous quantification of gene expression, streamlining workflows for transcriptional regulation studies. Its unique bioluminescence chemistry enables robust normalization and reproducibility, particularly in high-throughput settings where experimental accuracy and protocol speed are critical.
-
FPR2/ALX Stimulation Modulates Microglia to Limit CNS Autoim
2026-08-04
This study demonstrates that activating FPR2/ALX with Quin-C1 reduces neuroinflammation and demyelination in a mouse model of autoimmune astrocytopathy. The research delineates a SYK-AKT-dependent mechanism involving microglia and NK cells, highlighting a novel therapeutic avenue for neuroinflammatory diseases such as NMOSD.
-
Vasopressin Analogues: Multitasking Peptides in Translationa
2026-08-04
The reference study systematically reviews the evolution, pharmacology, and translational applications of vasopressin and its analogues, highlighting lypressin acetate as a natural peptide with well-defined vasopressor and antidiuretic properties. The paper also explores the cross-domain potential of these peptides, including emerging antiviral research, contributing to a nuanced understanding for peptide-based therapeutics and experimental protocols.
-
EdU Imaging Kits (Cy5): Precision S-Phase DNA Synthesis Dete
2026-08-03
EdU Imaging Kits (Cy5) offer ultrasensitive, morphology-preserving cell proliferation analysis, transforming workflows in both basic research and translational settings. Leveraging click chemistry and Cy5 fluorescence, the kit streamlines S-phase DNA synthesis measurement for microscopy and flow cytometry—delivering superior specificity and ease-of-use compared to BrdU assays.
-
Pazopanib Hydrochloride: Optimizing Cancer Research Assays
2026-08-03
Pazopanib Hydrochloride (GW786034) stands out as a robust multi-target kinase inhibitor for both in vitro and in vivo oncology workflows. This guide reveals optimized experimental protocols, troubleshooting insights, and actionable tips drawn from cutting-edge research, helping scientists maximize the utility of APExBIO’s high-purity reagent in anti-angiogenic and tumor growth studies.